| Careers

Contact Us

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

OPKO Health Receives Important U.S. Patent Allowance Read more

OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel Read more

OPKO Health Receives Important U.S. Patent Allowance Read more

OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV Read more

Name *
Email *
Subject *
Comments *
Type in number *
	This helps OPKO Health, Inc prevent automated submissions.